These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Antiphospholipid antibodies: clinical significance and biological diagnosis]. Arnoux D; Boutière B; Sanmarco M Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099 [TBL] [Abstract][Full Text] [Related]
3. [Phospholipid antibodies (lupus anticoagulant and cardiolipin antibodies). Detection and clinical significance]. Wisløff F; Sletnes KE; Schjetlein R Tidsskr Nor Laegeforen; 1993 Aug; 113(18):2269-72. PubMed ID: 8362396 [TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [TBL] [Abstract][Full Text] [Related]
5. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685 [TBL] [Abstract][Full Text] [Related]
6. [Clinical significance and predictive value of laboratory tests in thrombosis associated with antiphospolipid antibodies]. Barbui T; Finazzi G; Galli M Ann Ital Med Int; 1997; 12(2):76-83. PubMed ID: 9333316 [TBL] [Abstract][Full Text] [Related]
7. [New insights on disorders of haemostasis in the antiphospholipid syndrome]. Zawilska K Pol Arch Med Wewn; 2006 May; 115(5):491-9. PubMed ID: 17195368 [No Abstract] [Full Text] [Related]
9. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus. Cabral AR; Cabiedes J; Alarcón-Segovia D Lupus; 2004; 13(3):182-7. PubMed ID: 15119547 [TBL] [Abstract][Full Text] [Related]
10. IgA anticardiolipin antibodies--relation with other antiphospholipid antibodies and clinical significance. Selva-O'Callaghan A; Ordi-Ros J; Monegal-Ferran F; Martinez N; Cortes-Hernandez F; Vilardell-Tarres M Thromb Haemost; 1998 Feb; 79(2):282-5. PubMed ID: 9493576 [TBL] [Abstract][Full Text] [Related]
11. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis. Reynaud Q; Lega JC; Mismetti P; Chapelle C; Wahl D; Cathébras P; Laporte S Autoimmun Rev; 2014 Jun; 13(6):595-608. PubMed ID: 24418303 [TBL] [Abstract][Full Text] [Related]
12. Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort. Petri M Lupus; 2010 Apr; 19(4):419-23. PubMed ID: 20353980 [TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid antibodies: lessons from the bench. Koike T; Bohgaki M; Amengual O; Atsumi T J Autoimmun; 2007; 28(2-3):129-33. PubMed ID: 17383159 [TBL] [Abstract][Full Text] [Related]
19. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
20. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome]. Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]